- Home
- / Bioverativ
Bioverativ
Bioverativ Summary
Company Summary
- Overview
- Bioverativ is a biotechnology company that is focused on the discovery, research, development and commercialization of therapies for the treatment of hemophilia and other blood disorders. It markets approximately two products: Elocate and Alprolix, extended half-life clotting-factor therapies for the treatment of hemophilia A and hemophilia B, respectively.
- Type
- Subsidiary
- Status
- Closed
- Founded
- 2017
- HQ
- Waltham, MA, US | view all locations
- Website
- https://www.bioverativ.com
- Cybersecurity rating
- Sectors
Table of Contents
LocationsView all
5 locations detected
Waltham, MA HQ
United States
225 2nd Ave
South San Francisco, CA
United States
951 Gateway Blvd
Kew, Victoria
Australia
Suite 10, 79-83 High Street
Mississauga, Ontario
Canada
1101 90 Burnhamthorpe Rd W
Chūō-ku, Tōkyō-to
Japan
Nihonbashi 1-chome Mitsui Building 14F 4-1, Nihonbashi 1-chome
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026